# Corona Remedies Ltd (CORONA)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹1684.6
Day Change: -1.28%
52W High: ₹1949.4
52W Low: ₹1336.6
Market Cap: ₹10,881 Cr

## Valuation
P/E: 60.25
P/B: 16.89
EPS: ₹30.21
Book Value: ₹107.8
Dividend Yield: 0.41%

## Returns
1Y Return: 26.54%

## Profitability
ROE: 27.36%
ROCE: 31.43%
Debt/Equity: 0.22
Revenue Growth: 21.6%
Profit Growth: 43.6%
EBITDA Margin: 21.45%
Operating Margin: 15.63%

## About
Corona Remedies Ltd is a Drug Manufacturers - General company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - General
Sub Industry: Unknown

## Business Model
Overview: Corona Remedies Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - General. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Annual Secretarial Compliance Report For The Financial Year Ended March 31, 2026
- Announcement: Annual Secretarial Compliance Report For The Financial Year Ended March 31, 2026
- BSE Filing: Annual Secretarial Compliance Report For The Financial Year Ended March 31, 2026

## Data Freshness
Quote Updated: 2026-05-24T20:00:07.443Z
Price History Updated: 2026-05-18T22:58:25.436Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-18T22:58:25.436Z
Quant Updated: 2026-05-18T22:58:25.436Z
Sentiment Updated: 2026-05-18T22:58:25.436Z
Financials Status: current
Financials Updated: 2026-05-18T10:31:55.702Z
Financials Last Attempt: 2026-05-18T10:31:55.702Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2024)
Revenue: ₹884 Cr
Operating Profit: ₹128 Cr (OPM 14%)
Net Profit: ₹85 Cr
Tax: ₹111 Cr

## Annual P&L History
Mar 2024: Rev ₹884Cr | PAT ₹85Cr | OPM 14%
Mar 2025: Rev ₹1014Cr | PAT ₹90Cr | OPM 15%
Mar 2026: Rev ₹1196Cr | PAT ₹149Cr | OPM 20%

## Balance Sheet (Mar 2024)
Total Assets: ₹595 Cr
Total Liabilities: ₹595 Cr
Borrowings: ₹28 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%

## Board
- Niravkumar Kirtikumar Mehta, Founder, MD, CEO & Director
- Ankurbhai Kirtikumar Mehta, Co-Founder, Joint MD & Director
- Bhavin Naresh Bhagat, Chief Financial Officer
- Viral Bhupendrabhai Sitwala, Whole-Time Director
- Chetna Prabhat Kumar Dharajiya, Company Secretary & Compliance Officer

---
Source: rupiya.io/stocks/corona
Disclaimer: For research and education only. Not investment advice.